Spot the Difference - Development of a Syndrome Based Protein Microarray for Specific Serological Detection of Multiple Flavivirus Infections in Travelers

Uloženo v:
Podrobná bibliografie
Název: Spot the Difference - Development of a Syndrome Based Protein Microarray for Specific Serological Detection of Multiple Flavivirus Infections in Travelers
Autoři: Cleton, Natalie B., Godeke, Gert-Jan, Reimerink, Johan, Beersma, Mathias F., Doorn, H. Rogier van, Franco, Leticia, Goeijenbier, Marco, Jimenez-Clavero, Miguel A., Johnson, Barbara W., Niedrig, Matthias, Papa, Anna, Sambri, Vittorio, Tami, Adriana, Velasco-Salas, Zoraida I., Koopmans, Marion P. G., Reusken, Chantal B. E. M.
Informace o vydavateli: Robert Koch-Institut, Biologische Sicherheit
Rok vydání: 2015
Sbírka: Robert Koch Institute: Publications
Témata: Humans, Female, Male, Middle Aged, Cross Reactions, Antibodies Viral/blood, Travel, Epitopes, Flavivirus Infections/diagnosis, Protein Array Analysis/methods, Viral Nonstructural Proteins/genetics, Viral Nonstructural Proteins/immunology, 610 Medizin, ddc:610
Popis: Background: The family Flaviviridae, genus Flavivirus, holds many of the world’s most prevalent arboviral diseases that are also considered the most important travel related arboviral infections. In most cases, flavivirus diagnosis in travelers is primarily based on serology as viremia is often low and typically has already been reduced to undetectable levels when symptoms set in and patients seek medical attention. Serological differentiation between flaviviruses and the false-positive results caused by vaccination and cross-reactivity among the different species, are problematic for surveillance and diagnostics of flaviviruses. Their partially overlapping geographic distribution and symptoms, combined with increase in travel, and preexisting antibodies due to flavivirus vaccinations, expand the need for rapid and reliable multiplex diagnostic tests to supplement currently used methods. Goal: We describe the development of a multiplex serological protein microarray using recombinant NS1 proteins for detection of medically important viruses within the genus Flavivirus. Sera from clinical flavivirus patients were used for primary development of the protein microarray. Results: Results show a high IgG and IgM sensitivity and specificity for individual NS1 antigens, and limited cross reactivity, even within serocomplexes. In addition, the serology based on this array allows for discrimination between infection and vaccination response for JEV vaccine, and no cross-reactivity with TBEV and YFV vaccine induced antibodies when testing for antibodies to other flaviviruses. Conclusion: Based on these data, multiplex NS1-based protein microarray is a promising tool for surveillance and diagnosis of flaviviruses.
Druh dokumentu: article in journal/newspaper
Popis souboru: application/pdf
Jazyk: English
Relation: http://edoc.rki.de/oa/articles/reh38Kk1kzrjM/PDF/27P0kYj4YAUwc.pdf; http://edoc.rki.de/176904/2060; http://dx.doi.org/10.25646/1985
DOI: 10.1371/journal.pntd.0003580
DOI: 10.25646/1985
Dostupnost: http://edoc.rki.de/oa/articles/reh38Kk1kzrjM/PDF/27P0kYj4YAUwc.pdf
http://edoc.rki.de/176904/2060
https://nbn-resolving.org/urn:nbn:de:0257-10039441
https://doi.org/10.1371/journal.pntd.0003580
https://doi.org/10.25646/1985
Přístupové číslo: edsbas.19E588F8
Databáze: BASE
Popis
Abstrakt:Background: The family Flaviviridae, genus Flavivirus, holds many of the world’s most prevalent arboviral diseases that are also considered the most important travel related arboviral infections. In most cases, flavivirus diagnosis in travelers is primarily based on serology as viremia is often low and typically has already been reduced to undetectable levels when symptoms set in and patients seek medical attention. Serological differentiation between flaviviruses and the false-positive results caused by vaccination and cross-reactivity among the different species, are problematic for surveillance and diagnostics of flaviviruses. Their partially overlapping geographic distribution and symptoms, combined with increase in travel, and preexisting antibodies due to flavivirus vaccinations, expand the need for rapid and reliable multiplex diagnostic tests to supplement currently used methods. Goal: We describe the development of a multiplex serological protein microarray using recombinant NS1 proteins for detection of medically important viruses within the genus Flavivirus. Sera from clinical flavivirus patients were used for primary development of the protein microarray. Results: Results show a high IgG and IgM sensitivity and specificity for individual NS1 antigens, and limited cross reactivity, even within serocomplexes. In addition, the serology based on this array allows for discrimination between infection and vaccination response for JEV vaccine, and no cross-reactivity with TBEV and YFV vaccine induced antibodies when testing for antibodies to other flaviviruses. Conclusion: Based on these data, multiplex NS1-based protein microarray is a promising tool for surveillance and diagnosis of flaviviruses.
DOI:10.1371/journal.pntd.0003580